The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2024

Filed:

Aug. 25, 2022
Applicant:

Canna-chemistries Llc, Vincennes, IN (US);

Inventors:

Emily Rigsbee, Lafayette, IN (US);

David T. Jonaitis, Brookston, IN (US);

Nathan Schultheiss, West Lafayette, IN (US);

Lloyd Steven Miller, Indianapolis, IN (US);

Assignee:

CANNA CHEMISTRIES LLC, Vincennes, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/19 (2006.01); A23L 27/30 (2016.01); A23L 33/105 (2016.01); A61K 9/16 (2006.01); A61K 31/00 (2006.01); A61K 31/352 (2006.01); A61K 33/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A23L 27/33 (2016.08); A23L 33/105 (2016.08); A61K 9/1617 (2013.01); A61K 9/19 (2013.01); A23V 2002/00 (2013.01);
Abstract

The invention relates to a solid Δ-THC composition containing Δ-THC and a powder former and having a molar ratio of Δ-THC to powder former to form a flowable Δ-THC powder. The powder former is selected from the group consisting of adenine, aspartame, caffeine, lactose, mannitol, nicotinamide, β-nicotinamide adenine dinucleotide, pipecolic acid, saccharin, aspartic acid, glutamic acid, glutamine, histidine, leucine, methionine, phenylalanine, proline, serine, tryptophan, valine, Epigallocatechin Gallate (EGCG), 2-Hydroxypropyl-beta-cyclodextrin (HPbCD), and Trimethyl-beta-cyclodextrin (TOMBC) and mixtures thereof. The invention also relates to methods of making a solid Δ-THC composition of the invention. The Δ-THC may be synthetic Δ-THC or may be extracted Δ-THC. The invention provides pharmaceutical or nutraceutical composition containing a solid Δ-THC composition of the invention and a pharmaceutically- or nutraceutically-acceptable carrier where Δ-THC is present in a pharmaceutically or nutraceutically effective amount. The invention also provides methods of treating a disease, disorder, or condition by administering to a patient in need thereof a therapeutically effective amount of a solid Δ-THC composition. A solid Δ-THC composition of the invention may also be incorporated into food and beverage products.


Find Patent Forward Citations

Loading…